title: Summary of major conclusions.
authors.affiliation: Covance Laboratories Ltd, Otley Road, Harrogate, North Yorkshire HG3 1PY, UK. david.kirkland@covance.com
authors.forename: D J
authors.initials: DJ
authors.lastname: Kirkland
authors.forename: M
authors.initials: M
authors.lastname: Hayashi
authors.forename: J T
authors.initials: JT
authors.lastname: MacGregor
authors.forename: L
authors.initials: L
authors.lastname: Müller
authors.forename: L M
authors.initials: LM
authors.lastname: Schechtman
authors.forename: T
authors.initials: T
authors.lastname: Sofuni
mesh_terms: D000818:Animals; D001681:Biological Assay / Q000592:standards*; D008223:Lymphoma / Q000378:metabolism; D051379:Mice; D048629:Micronuclei, Chromosome-Defective / Q000235:genetics / Q000378:metabolism; D009152:Mutagenicity Tests / Q000592:standards; D009153:Mutagens / Q000145:classification; D016159:Tumor Suppressor Protein p53 / Q000172:deficiency; D018631:ras Proteins / Q000235:genetics / Q000378:metabolism
chemical_list: D009153:Mutagens; D016159:Tumor Suppressor Protein p53; D018631:ras Proteins